| 4DG1: reference: HIV-1 reverse transcriptase (RT) polymorphism 172K, suppresses the effect of clinically relevant drug resistance mutations to both nucleoside and nonnucleoside RT inhibitors., Hachiya A, Marchand B, Kirby KA, Michailidis E, Tu X, Palczewski K, Ong YT, Li Z, Griffin DT, Schuckmann MM, Tanuma J, Oka S, Singh K, Kodama EN, Sarafianos SG, J Biol Chem. 2012 Jul 2. PMID: 22761416 |
This OCA 
Structure page
uses Jmol,
developed by the Jmol Development Team
(documentation).